Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,405Revenue $M2,371Net Margin (%)5.8Altman Z-Score3.8
Enterprise Value $M3,730EPS $2.5Operating Margin %7.7Piotroski F-Score5
P/E(ttm)24.5Beneish M-Score-2.9Pre-tax Margin (%)7.6Higher ROA y-yY
Price/Book6.110-y EBITDA Growth Rate %16.9Quick Ratio1.4Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %19.9Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow35.4y-y EBITDA Growth Rate %-6.2ROA % (ttm)7.5Higher Current Ratio y-yN
Dividend Yield %--PEG1.2ROE % (ttm)23.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M53.2ROIC % (ttm)18.5Gross Margin Increase y-yN

Gurus Latest Trades with PRXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRXLVanguard Health Care Fund 2015-12-31 Reduce-0.19%$58 - $68.99
($65.21)
$ 59.76-8%Reduce -41.52%2,015,640
PRXLKen Fisher 2015-12-31 Reduce-0.01%$58 - $68.99
($65.13)
$ 59.76-8%Reduce -1.58%2,355,456
PRXLJoel Greenblatt 2015-09-30 Reduce-0.11%$61.42 - $74.01
($67.26)
$ 59.76-11%Reduce -22.53%711,727
PRXLVanguard Health Care Fund 2015-09-30 Reduce-0.04%$61.42 - $74.01
($67.26)
$ 59.76-11%Reduce -9.06%3,446,741
PRXLKen Fisher 2015-09-30 Reduce$61.42 - $74.01
($67.26)
$ 59.76-11%Reduce -1.58%2,393,327
PRXLJoel Greenblatt 2015-06-30 Reduce-0.18%$63.58 - $72.57
($67.41)
$ 59.76-11%Reduce -27.44%918,656
PRXLKen Fisher 2015-06-30 Reduce$63.58 - $72.57
($67.41)
$ 59.76-11%Reduce -0.32%2,431,850
PRXLJoel Greenblatt 2015-03-31 Reduce-0.08%$55.94 - $70.12
($63.74)
$ 59.76-6%Reduce -12.74%1,265,994
PRXLVanguard Health Care Fund 2015-03-31 Reduce-0.07%$55.94 - $70.12
($63.74)
$ 59.76-6%Reduce -11.70%3,790,200
PRXLKen Fisher 2015-03-31 Reduce$55.94 - $70.12
($63.74)
$ 59.76-6%Reduce -0.65%2,439,694
PRXLJoel Greenblatt 2014-12-31 Add0.3%$52.86 - $64.01
($57.63)
$ 59.764%Add 87.36%1,450,825
PRXLVanguard Health Care Fund 2014-12-31 Reduce-0.13%$52.86 - $64.01
($57.7)
$ 59.764%Reduce -15.46%4,292,200
PRXLJoel Greenblatt 2014-09-30 Add0.31%$52.97 - $64.26
($57.05)
$ 59.765%Add 169.71%774,370
PRXLJoel Greenblatt 2014-06-30 Add0.12%$43.94 - $55.47
($50.11)
$ 59.7619%Add 177.29%287,113
PRXLVanguard Health Care Fund 2014-06-30 Add0.04%$43.94 - $55.47
($50.22)
$ 59.7619%Add 5.65%5,077,400
PRXLKen Fisher 2014-06-30 Reduce-0.01%$43.94 - $55.47
($50.22)
$ 59.7619%Reduce -2.32%2,475,274
PRXLJoel Greenblatt 2014-03-31 Add0.07%$45.18 - $56.94
($51.01)
$ 59.7617%Add 361.66%103,542
PRXLVanguard Health Care Fund 2013-12-31 Add0.26%$38.93 - $54.85
($45.69)
$ 59.7631%Add 63.66%4,805,700
PRXLJoel Greenblatt 2013-12-31 Reduce-0.04%$38.93 - $54.85
($45.69)
$ 59.7631%Reduce -51.75%22,428
PRXLJoel Greenblatt 2013-09-30 Reduce-0.12%$46.43 - $51.33
($48.98)
$ 59.7622%Reduce -57.22%46,486
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PRXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOVE RICHARD LDirector 2015-12-01Sell1,330$68.21-12.39view
Holdener Eduard E.Director 2015-11-24Sell2,200$67.66-11.68view
Saarony GadiSenior Vice President, CRS 2015-11-12Sell12,425$67.01-10.82view
FORTUNE PATRICK JDirector 2015-11-11Sell1,500$68.07-12.21view
LOVE RICHARD LDirector 2015-09-01Sell1,330$64.26-7view
GOLDBERG MARK APresident & COO 2015-08-18Sell8,995$73.49-18.68view
Senderovitz ThomasSenior Vice President, CRS 2015-08-18Sell1,500$74.02-19.27view
BATT DOUGLAS ASVP, General Counsel & Sec. 2015-08-18Sell5,000$74.05-19.3view
GOLDBERG MARK APresident & COO 2015-06-18Sell11,507$70.03-14.67view
LOVE RICHARD LDirector 2015-05-14Sell5,000$65-8.06view

Quarterly/Annual Reports about PRXL:

News about PRXL:

Articles On GuruFocus.com
Parexcel: Great Growth but a Tough Business Aug 17 2011 
PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 12,920 Shares Mar 11 2011 
PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 1,500 Shares Mar 11 2011 
PAREXEL International Corp. Reports Operating Results (10-Q) Feb 09 2011 
PAREXEL International Corp. Reports Operating Results (10-Q) Nov 09 2010 
PAREXEL International Corp. Reports Operating Results (10-K/A) Sep 09 2010 
PAREXEL International Corp. Reports Operating Results (10-K) Aug 27 2010 
PAREXEL International Corp. Reports Operating Results (10-Q) May 07 2010 
PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 13,149 Shares Mar 12 2010 
PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 15,600 Shares Mar 04 2010 

More From Other Websites
PAREXEL INTERNATIONAL CORP Financials Feb 05 2016
PAREXEL INTERNATIONAL CORP Files SEC form 10-Q, Quarterly Report Feb 02 2016
PAREXEL International Corp. Earnings Analysis: Q2, 2016 By the Numbers Jan 29 2016
Edited Transcript of PRXL earnings conference call or presentation 28-Jan-16 3:00pm GMT Jan 28 2016
PAREXEL International Corp Earnings Call scheduled for 10:00 am ET today Jan 28 2016
PAREXEL International Q2 Earnings Beat, FY16 View Slashed Jan 28 2016
PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 27 2016
PAREXEL International Reports Second Quarter Fiscal Year 2016 Results Jan 27 2016
PAREXEL International Reports Second Quarter Fiscal Year 2016 Results Jan 27 2016
Q2 2016 PAREXEL International Corp Earnings Release - After Market Close Jan 27 2016
Avondale Downgrades PAREXEL To Underperform, Cites MSA-Laden Backlog Concerns Jan 25 2016
PAREXEL downgraded by Avondale Jan 25 2016
Optum and PAREXEL to Accelerate Drug Development, Reimbursement and Market Access with EHR-Fueled... Jan 21 2016
Optum and PAREXEL to Accelerate Drug Development, Reimbursement and Market Access with EHR-Fueled... Jan 21 2016
PAREXEL International Set to Acquire Health Advances Jan 20 2016
Parexel buys 120-employee Waltham-based life sciences consulting firm Jan 19 2016
PAREXEL Announces Execution of Definitive Agreement to Acquire Health Advances Jan 19 2016
PAREXEL Announces Execution of Definitive Agreement to Acquire Health Advances Jan 19 2016
PAREXEL International Corp. breached its 50 day moving average in a Bearish Manner : January 12,... Jan 12 2016
PAREXEL International to Present at JP Morgan Healthcare Conference Jan 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK